Eflapegrastim, a human IgG4 monoclonal antibody, functions as a granulocyte colony-stimulating factor (G-CSF). This biologic specifically binds to the G-CSF receptor (c-Fms), playing a crucial role in the hematopoietic system. It effectively stimulates the proliferation and differentiation of neutrophil progenitor cells, ensuring the maintenance of adequate levels of mature and functional neutrophils. Additionally, Eflapegrastim is instrumental in reducing the duration of neutropenia, thereby enhancing patient recovery and resilience in clinical settings. This makes it an essential therapeutic agent in managing conditions associated with reduced neutrophil counts, such as those experienced during chemotherapy.
Eflapegrastim, a human IgG4 monoclonal antibody, functions as a granulocyte colony-stimulating factor (G-CSF). This biologic specifically binds to the G-CSF receptor (c-Fms), playing a crucial role in the hematopoietic system. It effectively stimulates the proliferation and differentiation of neutrophil progenitor cells, ensuring the maintenance of adequate levels of mature and functional neutrophils. Additionally, Eflapegrastim is instrumental in reducing the duration of neutropenia, thereby enhancing patient recovery and resilience in clinical settings. This makes it an essential therapeutic agent in managing conditions associated with reduced neutrophil counts, such as those experienced during chemotherapy.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
